Back to Home Page of CD3WD Project or Back to list of CD3WD Publications

CLOSE THIS BOOKFact sheet No 259: African Trypanosomiasis or Sleeping Sickness - March 2001 (WHO, 2001, 4 p.)
VIEW THE DOCUMENT(introduction...)
VIEW THE DOCUMENTDefinition of the disease
VIEW THE DOCUMENTAnimal trypanosomiasis
VIEW THE DOCUMENTMajor epidemics
VIEW THE DOCUMENTThe Geographical distribution of the disease
VIEW THE DOCUMENTInfection and symptoms
VIEW THE DOCUMENTCase management
VIEW THE DOCUMENTTreatment
VIEW THE DOCUMENTFirst phase treatments
VIEW THE DOCUMENTSecond phase treatments
VIEW THE DOCUMENTThe Role of the World Health Organization

Infection and symptoms

The disease is transmitted with the bite of the tsetse fly. At first the trypanosomes multiply in the blood, and that process can last for years with T.b. gambiense.

· Mother-to-child infection: the trypanosome can cross the placenta and infect the fetus, causing abortion and perinatal death.

· Accidental infections can occur in laboratories, for example, through the handling of blood of an infected person, although this is fairly rare.

The early phase entails bouts of fever, headaches, pains in the joints and itching. The second, known as the neurological phase, begins when the parasite crosses the blood-brain barrier and infests the central nervous system. This is when the characteristic signs and symptoms of the disease appear: confusion, sensory disturbances and poor coordination. Disturbance of the sleep cycle, which gives the disease its name, is the most important feature. Without treatment, the disease is fatal. If the patient does not receive treatment before the onset of the second phase, neurological damage is irreversible even after treatment.

TO PREVIOUS SECTION OF BOOK TO NEXT SECTION OF BOOK